The need for scientific research in sports medicine
Frost & Sullivan’s TechCasting Group, argues for increasing awareness of the need for scientific research in sports medicine.
The expanding scope of cannabinoids in epilepsy
Arun Swaminathan MD, Assistant Professor of Neurology and Epilepsy at the University of Nebraska Medical Center, details the expanding scope of cannabinoids in epilepsy.
Benchmarking Regulatory systems governing veterinary medicines – part 3
Rick Clayton, Technical Director, AnimalhealthEurope, in the final chapter of this three-part series, examines the benefits of benchmarking regulatory systems and promoting Good Regulatory Practice.
COVID-19: Challenges of vaccination logistics
The challenges of vaccination logistics during the COVID-19 pandemic are charted in this updated view, written by Zisis Kozlakidis and John Litaker.
High stakes: Is the UK finally clearing a pathway for cannabis investments?
John Binns, Partner at BCL Solicitors LLP says it’s high stakes when it comes to the UK finally clearing a pathway towards cannabis investments.
Cholesterol medication may reduce COVID-19 severity
Researchers have confirmed that statin medication lower the risk of in-hospital death from COVID-19, following a new study.
Ensuring regulatory compliance for Medical Cannabis
Here, Evolve Ltd’s Managing Director, Christopher Busuttil Delbridge, takes us progressively deeper into what it takes to ensure regulatory compliance for Medical Cannabis.
CBD oil for pain: What the research shows
Oils by Simpson of 2012 supplies organic full-spectrum CBD cannabis oil products. CBD oil is popular and commonly used for its potent therapeutic benefits, but what about its effect on pain? Here’s what the research shows.
Canvassing public awareness on veterinary medicines
Roxane Feller, Secretary General of AnimalhealthEurope, explains to us canvassing public awareness on the benefits of veterinary medicines.
Commission signs third contract for 1.8 billion BioNTech-Pfizer doses
The European Commission has announced that it has signed a third contract to secure an additional 1.8 billion BioNTech-Pfizer vaccine doses.
Logistics & supply chain will win the COVID-19 war
Professor Richard Wilding argues that biochemistry is winning the battle against coronavirus, but logistics and supply chain will win the war.
Will 2021 see the UK’s cannabis industry bloom?
John Binns & David Hardstaff from BCL Solicitors LLP, reveal if 2021 will be the year that sees the UK’s cannabis industry bloom.
Benchmarking Regulatory systems governing veterinary medicines – part 2
Rick Clayton, Technical Director, AnimalhealthEurope, in the second chapter of this three-part series, continues to examine Benchmarking Regulatory systems governing veterinary medicines.
Why COVID vaccine development was exceptionally speedy
Ram May-Ron, Managing Partner at FreeMind Group, explains why COVID vaccine development was exceptionally speedy.
Countries denied access to vaccines they helped develop
A new study has revealed that new medicines and vaccines approved for use in the United States are often unavailable in countries that helped to develop them.
COVID-19 variant vaccines will be fast-tracked through cutting-edge testing centre
Health Secretary Matt Hancock has announced that vaccines tailored to tackle COVID-19 variants will be fast-tracked through new state-of-the-art labs.
Combination of remdesivir and hep C drugs effective against COVID-19
A combination of remdesivir and drugs for hepatitis C virus (HCV) have presented strong effectiveness against COVID-19 in a new study.
CBD oil for ADHD: What the research shows
CBD oil is popular for its wide-ranging therapeutic benefits, but what about its effects on ADHD? Here’s what the research shows.
Cannabis as a treatment for COVID-19
Kevin William Simpson, CEO and Founder of OilsBySimpson, tells us about the growing evidence around cannabis as a treatment for COVID-19.
CBD Novel Foods in the UK
Lead Scientific Officer at Always Pure Organics Andrew Megahy, explains how the UK is now in a prime position for the future of CBD use, due to the Novel Foods Application.
